CD274 and neoplasm: However, TNBC exhibits a propensity to be responsive to immunotherapies, particularly when the tumor displays a high TMB (tumor mutational burden) and PD-L1 levels while abundant lymphocytes infiltrating—all indicators of an immunogenic tumor microenvironment (4, 5).